Skip to Main Content
Skip Nav Destination

A review of a recently published guidelines' “strong recommendation” for therapeutic drug monitoring of olanzapine, haloperidol, perphenazine, and fluphenazine

Mental Health Clinician (2019) 9 (4): 287–293.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Jens Borggaard Larsen
  • Elke Hoffmann-Lücke
  • Per Hersom Aaslo
  • Niklas Rye Jørgensen
  • Eva Greibe
Pharmaceutics (2023) 15 (2): 673.
  • Jose M. Rubio
  • Todd Lencz
  • Anita Barber
  • Ashley Moyett
  • Sana Ali
  • Franchesica Bassaw
  • Gabriela Ventura
  • Nicole Germano
  • Anil K. Malhotra
  • John M. Kane
Schizophrenia Research (2022) 243: 342.
Close Modal

or Create an Account

Close Modal
Close Modal